CO’s unique biological effects have been recognized and heavily studied in various academic laboratories around the world over the past 50 years. These studies have demonstrated clear and significant therapeutic potential in cytoprotection, inflammation, fibrosis and immunomodulation, which Proterris is developing into specific products for a number of diseases and conditions. These are depicted below.

Indeed, the science behind CO’s therapeutic potential was significantly generated by our co-founders and validated and extended by numerous other investigators, all of whose pioneering translational and clinical development work has paved the way for Proterris’ further development strategies. These are principally focused on organ transplant, nephrology and respiratory indications.